Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-FR
Language French French
Date Updated 2019-03-21 2019-03-21
Drug Identification Number 02382555 02382555
Brand name APO-VALSARTAN/HCTZ APO-VALSARTAN/HCTZ
Common or Proper name VALSARTAN/HCTZ VALSARTAN/HCTZ
Company Name APOTEX INC APOTEX INC
Ingredients HYDROCHLOROTHIAZIDE VALSARTAN HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 12.5MG 160MG 12.5MG 160MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL & 30 BLS 100 BTL & 30 BLS
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-01-04 2016-01-04
Estimated end date
Actual end date 2018-12-28 2018-12-28
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments